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Abstract
Background: The aim of the current study was to identify a possible locus of dysfunction in the
visual system of depressed patients.
Materials and Methods: Fifty Major Depressive patients aged 21–60 years and 15 age-matched
controls took part in the study The diagnosis was obtained with the SCAN v 2.0. The psychometric
assessment included the HDRS, the HAS, the Newcastle Scales, the Diagnostic Melancholia Scale
and the GAF scale. Flash Electroretinogram and Electrooculogram were performed in all subjects.
The statistical analysis included ANCOVA, Student's t-test and Pearson Product Moment
Correlation Coefficient were used.
Results: The Electro-oculographic findings suggested that all subtypes of depressed patients had
lower dark trough and light peak values in comparison to controls (p < 0.001), while Arden ratios
were within normal range. Electroretinographic recordings did not reveal any differences between
patients and controls or between subtypes of depression.
Discussion: The findings of the current study provide empirical data in order to assist in the
understanding of the international literature and to explain the mechanism of action of therapies
like sleep deprivation and light therapy.
Background
Depression, according to recent epidemiological surveys
might affect almost 25% of the general population at
some point of their lives. The definition of 'depression'
according to both classification systems [1-3], is based on
the definition of the depressive episode. Modern classifi-
cation systems recognise melancholic ('somatic) and
atypical features. In spite of early reports [4-7], today the
only report which seems to survive is not the favourable
response of atypical patients to MAOIs, but their resist-
ance to TCAs.
One of the theories concerning the etiopathogenesis of
depression suggests that a disturbance of biological
rhythms is the core feature [8]. This disturbance is better
studied in Seasonal Affective Disorder (SAD), which is a
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form of depression which responds to light therapy. It is
possible that similar disturbances might be also present in
non-seasonal depression, since these patients respond to
sleep deprivation, especially in combination to light ther-
apy. Additionally, there is a direct connection of the
hypothalamus with the retina (retinohypothalamic tract)
and some authors believe that at least 40% of brain neu-
rones carry or process visual information [9].
A neglected area concerns the contribution of the visual
system to the genesis of the circadian rhythms of the
organism. Especially the direct assessment of retinal func-
tion would be valuable [10]. The suprachiasmatic nucleus
is believed to be the center of the production of these
rhythms. It processes information originating from the
retina. Our group has already published papers on the vis-
ual system of depressives [11,12] and Alzheimer disease
patients [13] using pupillometry. In a recent study of our
group [14] the use of PR-VEPs revealed that there might be
an underactivation of the anterior right hemisphere in
melancholic depressives (anterior to the chiasm) and a
hyperactivation of the same region in atypical depressives.
The question which arises is whether there is a specific
dysfunction at the level of the pigmentum epithelium or
the retina responsible for these findings.
The present study aimed to investigate the outer part of
the visual system of depressed patients and to provide evi-
dence for further localization of a suggested anterior right
hemisphere dysfunction in depression. Also aimed to
compare the results of normal controls with those of
depressed patients and to compare depressed subtypes
between each other.
Materials and methods
Study Participants
Fifty (50) patients (15 males and 35 females) aged 21–60
years (mean = 41.0, standard deviation = 11.4) and 15
controls (4 males and 11 females) aged 20–55 years
(mean 35.2, standard deviation = 9.2) suffering from
Major Depression according to DSM-IV [2], and depres-
sion according to ICD-10 [15] criteria, took part in the
study. All provided written informed consent. Fourteen of
them fulfilled criteria for atypical features, 16 for melan-
cholic features and 32 for somatic syndrome (according to
ICD-10). Also, 9 patients did not fulfilled criteria for any
specific syndrome (undifferentiated patients).
All were inpatients or outpatients of the 3rd Department of
Psychiatry, Aristotle University of Thessaloniki, University
Hospital AHEPA, Thessaloniki Greece. They constituted
the total number of patients during a two-years period
that fulfilled the criteria to enter in the study. These crite-
ria demanded that patients:
1. Be free of any medication for at least two weeks prior to
the first assessment and diagnosis. In no case medication
was interrupted in order to include the patient in the
study.
2. Be physically healthy with normal clinical and labora-
tory findings, including EEG, ECG and thyroid function.
3. Opthalmological examination should be normal and
patients should have normal or corrected visual acuity
and went through a full ophthalmologic investigation.
4. No patient should fulfill criteria for catatonic or psy-
chotic features or for seasonal affective disorder.
5. Also, no patient should fulfill criteria for another DSM-
IV axis-I disorder, except from generalised anxiety disor-
der and panic disorder
6. No past history of manic or hypomanic episode.
7. Psychiatric history of no more than five distinct epi-
sodes including the present one (mean 1.16 ± 1.53).
8. Patients should be right-handed and the right eye to be
the dominant one.
9. All should be born and lived in the area of Thessaloniki,
Greece (Latitude 40–40.1° North).
10. All should be depressed during testing.
Finally, the study sample of the current paper is identical
with that of our previous study on PR-VEPs in depression
[14].
Clinical Diagnosis
The Schedules for Clinical Assessment in Neuropsychiatry
version 2.0 (SCAN v 2.0) [16] were used for the clinical
diagnosis. Each one of the symptoms (according the lists
of both classification systems) was recorded and corre-
lated with the laboratory findings.
Laboratory Testing
It included ECG, EEG, blood and biochemical testing, test
for pregnancy, T3, T4, TSH, B12 and folic acid.
Psychometric Assessment
Its aim was the quantification of depression and anxiety
[17,18]. This was achieved with the use of the Hamilton
Depression Rating Scale (HDRS) [19,20] and the Hamil-
ton Anxiety Scale (HAS) [21] and their subscales. The
assessment of the endogeneity of depression was achieved
with the use of the Newcastle Scales (1965 Newcastle
Depression Diagnostic Scale-1965-NDDS and 1971Annals of General Psychiatry 2005, 4:7 http://www.annals-general-psychiatry.com/content/4/1/7
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Newcastle Depression Diagnostic Scale-1971-NDDS) and
the Diagnostic Melancholia Scale (DMS). These three
scales have a different rational in assessing the 'endog-
enous-melancholic' and the 'neurotic' syndromes of
depression. The General Assessment of Functioning Scale
(GAF) [22] was used to assess the severity of depression.
The questionnaire of Holmes [23] was used to search for
stressful life events during the last 6 months before the
onset of the symptomatology.
Psychophysiological Methods
It included:
1. Electro-oculogram (EOG)
which is a method with which one can study the electrical
and metabolic activity of the outer layers of the retina.
During the adaptation of the retina to dark, the amplitude
of the EOG gradually decreases, reaching a nadir (dark
trough). During the adaptation to light (ganzfeld, 1200
lux) it gradualy increases reaching a zenith (light peak).
The systematic development of the method of electro-ocu-
logram was made mainly by Arden [24,25] and the condi-
tions for EOG recording have been coded by the
International Society for Clinical Electrophysiology of
Vision (ISCEV) [26] and this was kept in the current study.
However some deviations from these conditions were
inevitable. These included the use of 3 instead of 4 elec-
trodes, the recording every 2 min for 12 minutes duration
instead of every minute for a 15 minutes duration and not
dilatated pupils.
A video camera was used to verify that the patients were
following the instructions and moved eyes to catch the
alternating lights.
EOG was recorded by two electrodes attached in the outer
canthous (Lc and Rc) and a third in the mideye (Mr). The
movement of the eyes produces a change of potential,
which is recorded by the electrodes. After the recording of
several movements of the eyes, the averaging of potentials
gives the mean potential for the given conditions (interac-
tion of time with lighting conditions). The procedure
includes recordings of eye movents every 2 minutes, for
12 minutes in dark and subsequently 12 minutes in light.
The resulting recording is shown in figure 1(a).
There is no difference of the recorded EOG curves between
the two eyes [27]. The most widely used indices for the
interpretation of the EOG are the Arden ratio:
The normal values of this index lie between 162 and 228,
but values under 180 should be considered as borderline.
Another index, which also takes into consideration the
baseline potential is the A criterion [28]:
A Criterion = light peak-[0, 61*baseline poten-
tial+0,91*dark trough].
According to Pinckers over of 70% of healthy subjects
have A-Criterion values over 80 and all over zero.
2. Flash-Electroretinogram
This is a method of recording potentials of the retina after
the fall of light stimuli. The Electroretinogram (ERG) can
be recorded after flash (f-ERG) or Pattern-Reversal (PR-
ERG) stimulation. In the current study, binocular f-ERG
was used. ERG recording have been coded by the Interna-
tional Society for Clinical Electrophysiology of Vision
(ISCEV) and this was kept in the current study. However
some deviations from these conditions were inevitable.
These included the use of skin electrodes, and lack of max-
imum dilatation of the pupil. The f-ERG curve includes
mainly the waves a and b. Wave a is photochemical in ori-
gin and is produced in the photoreceptors as their
respond to a light stimuli and under specific conditons
(scotopic conditions) the a wave may be split to ap and as
waves [29]. It is believed that the ap wave comes from the
cones and as wave from the rods [30]. The b-wave is pro-
duced by the bioelectrical activity of the neurons of the
inner grannule layer and the bipolar cells. It is neuronal in
origin. It can also be split (under scotopic conditions) in
two waves, named bp and bs.
In the current study, f-ERG was recorded from two elec-
trodes, attached below the eyes (Lr and Rr) and a reference
electrode at the mid-eye (Mr), under photopic conditions
from both eyes simultaneously (binocular).
3. Specific Issues
All recordings were conducted around mid-day (12:00 h
to 16:00 h) and there was no difference in the times of the
day or the season of the year the groups were studied.
Gold-plated silver electrodes were used and the imped-
ance was <4 kohms. All patients came from North Greece
(Latitude 40–40.1° North).
Statistical analysis
It included Analysis of Covariance (ANCOVA) with age as
a covariate and Pearson's product moment correlation
coefficient. Student's t-test was used for post-hoc
comparisons.
Since 8 ANCOVAs were performed, the Bonferonni
method suggests that the appropriate p-level should be
<0.00625, and for practical reasons the level p < 0.005 was
chosen and used also in post-hoc comparisons.
A
light peak
dark trough
rdenRatio =
−
−
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A. Electro-oculogram (EOG) Figure 1
A. Electro-oculogram (EOG). Recording in a normal control (upper), an atypical (middle-continuous line) and a melan-
cholic patient (lower-dotted line). The control subject has Arden ratio = 224, the melancholic Arden ratio = 295, and the atyp-
ical patient Arden ratio = 248. However, although all ratios are within normal limits, the curves of the depressed patients have 
lower amplitude. B. flash-ERG. Upper: normal latency of a and b waves (control subject) Lower: slightly increased than nor-
mal latency of a and b waves (melancholic patient) All recordings are within normal range.Annals of General Psychiatry 2005, 4:7 http://www.annals-general-psychiatry.com/content/4/1/7
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Results
Depressed patients and controls had similar gender com-
position and did not differ in age (p = 0.107, table 1). Mel-
ancholic patients seemed to be marginally older (table 2).
This is why age was used as covariate.
a. EOG
Depressed patients (as a whole), manifested a decrease of
both dark trough and light peak values in comparison to
controls. This did not hold true for Arden ratios or A-Cri-
terion values which both were within normal range (table
1). This was true both for melancholic and atypical
patients. The comparison between melancholic and atyp-
ical patients provided no significant results (table 2).
However, both groups differed from controls.
Correlation analysis included only depressed patients.
Both Arden ratios related negatively with the score in
NDDS 1965, but this was significant only from the left eye
(R = -0.48, p < 0.01). Left Arden ratio marginally corre-
lated with the number of life events (R = 0.46), and the
HDRS anxiety index (R = -0.47).
Concerning the existence of individual symptoms, accord-
ing to DSM-IV and ICD-10 lists, patients with 'distinct
quality of depressed mood' had lower right Arden ratio
values (p < 0.001); patients who were 'worse in the morn-
ing' had lower right Arden ratio and right A-Criterion val-
ues (p < 0.001) and higher right dark trough values (p <
0.001).
b. flash-ERG
Flash-ERG results suggested no differences between
depressed patients and controls (table 1), nor between
specific symptoms and controls exist (table 2).
There were correlations between b-wave latency and GAF
(left eye, R = -0.55), number of atypical features (right eye,
R = -0.50), number of life events (left eye, R = -0.49), non-
specific HDRS index (bilaterally, R = 0.51).
There was also a positive correlation between HDRS
depressed index and b-wave amplitude bilaterally (R =
0.52).
Concerning the existence of individual symptoms, accord-
ing to DSM-IV and ICD-10 lists, patients with 'melan-
cholic anhedonia' had bilaterally larger b- wave latency
and those with 'thoughts of death' (present at the time of
clinical interview) had prolonged b- wave latency (p <
0.001)
Table 1: Results of Electrooculographic and flash-Electroretinographic recordings of depressed patients and controls and p-values after 
ANCOVA with age as covariate.
depressed patients N = 50 Controls N = 15
Mean S.D. Mean S.D. P (ANCOVA) P (post-hoc)
Age 41.0 11.4 35.2 9.2 0.107
EOG results 0.001
Left Dark Trough 178.54 55.93 284.08 109.46 0.000
Left Light Peak 455.22 127.11 659.17 195.72 0.000
Right Dark Trough 169.32 54.74 283.08 96.72 0.000
Right Light Peak 402.40 104.13 646.58 183.92 0.000
Left Arden Ratio 261.04 49.67 241.88 44.81 0.227
Right Arden Ratio 248.47 53.87 233.81 34.94 0.374
Left A-Criterio 153.21 71.40 142.11 65.66 0.287
Right A-Criterio 118.40 66.41 131.85 69.12 0.534
F-ERG Photopic 
Conditions
0.147
Lr a wave, ampl 4.54 1.96 4.63 1.57
Lr a wave, lat 13.99 1.15 13.17 1.47
Lr b wave, ampl 8.30 2.58 10.83 8.22
Lr b wave, lat 31.85 2.85 29.53 4.62
Rr a wave, ampl 4.51 1.75 4.30 1.71
Rr a wave, lat 13.88 1.50 13.37 1.71
Rr b wave, ampl 7.92 2.59 11.08 8.14
Rr b wave, lat 31.94 2.87 29.57 4.68Annals of General Psychiatry 2005, 4:7 http://www.annals-general-psychiatry.com/content/4/1/7
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Discussion
The alteration between light and dark produces electro-
chemical changes in the retina. The electro-oculogram
(EOG) is a technique suitable for the study of the electrical
and metabolic activity of the outer layers of the retina. The
fall of a light stimuli on the retina produces early and late
potentials. The method of recording late potentials is the
Electroretinogram (ERG). ERG provides information
about the functioning of the photoreceptors and the neu-
ronal elements of the retina.
Both EOG and ERG in fact are useful indices reflecting
dopamine activity. There are several studies in the interna-
tional literature concerning the relationship of dopamine
with specific depressive symptoms.
There is no report in the international literature on a com-
bined use of EOG and ERG in depression. There are only
papers using either method. This is one of the reasons the
results and interpretations are inconclusive and
problematic.
a. EOG
The current study reports that although Arden ratios and
A-criteria were within normal limits, both dark trough
and light peak were reduced in all subtypes of depression.
Table 2: Comparison between melancholic and atypical patients and controls (ANCOVA with age as covariate; significant are p-values 
below 0.005).
mean s.d. mean s.d. p p p p p p
Atypical features 
N = 14
Melancholic features 
N = 16
A/M 
ANCOV
A
A/M 
Post-hoc
A/C 
ANCOV
A
A/C 
Post-hoc
M/C 
ANCOV
A
M/C 
Post-hoc
Age 37.00 7.79 47.00 13.03 0.016 0.575 0.007
Age of Onset 27.21 8.74 34.68 12.83 0.070 - -
Number of 
previous 
episodes
1.21 1.37 1.21 1.69 0.995 - -
GAF 60.36 10.65 41.16 12.10 0.000 --
Number of PD 
diagnosed
0.50 0.65 0.16 0.37 0.066 - -
Number of PD 
criteria fulfilled
3.29 4.14 2.26 3.96 0.477 - -
Number of 
stressful life 
events
3.64 2.27 1.21 1.44 0.001 --
HDRS-17 23.14 3.82 28.53 6.54 0.010 - -
EOG 0.510 0.004 0.001
Left dark trough 187.86 47.31 181.84 49.22 0.006 0.001
Left light peak 488.50 132.98 443.16 124.36 0.015 0.001
Right dark 
trough
175.57 48.39 191.74 54.57 0.001 0.002
Right light peak 421.14 133.78 422.21 85.18 0.001 0.000
Left Arden ratio 262.95 47.09 246.03 40.03 0.256 0.790
Right Arden 
ratio
242.73 44.30 230.94 56.65 0.579 0.876
Flash-ERG 
Photopic 
Conditions
0.175 0.714 0.142
Lr a wave, ampl 4.08 1.97 4.70 1.89
Lr a wave, lat 13.38 1.42 14.37 0.75
Lr b wave, ampl 7.44 2.19 8.80 1.50
Lr b wave, lat 30.00 3.42 33.00 1.86
Rr a wave, ampl 4.12 1.35 4.67 1.84
Rr a wave, lat 13.31 1.30 14.14 1.63
Rr b wave, ampl 6.73 2.64 8.51 1.95
Rr b wave, lat 30.12 3.42 33.19 2.23Annals of General Psychiatry 2005, 4:7 http://www.annals-general-psychiatry.com/content/4/1/7
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However, different mechanisms are reported to underlie
them [31]. The light peak is related mostly to the intensity
of the stimuli, while the dark through does not. Also, the
light peak is related to the pre-adaptation level of the ret-
ina, while the dark trough is stable after only 2 minutes in
dark. Generally, the standing potential of the eye mani-
fests a diurnal rhythm, similar to that of the body
temperature. It seems that after 15 minutes of adaptation
to darkness, the amplitude of the dark trough is related
only to the diurnal rhythm (in normal subjects).
The correlations between EOG variables and clinical pic-
ture and psychometric scales suggested that the core fea-
ture was the relationship of the dark trough with
melancholic symptoms (NDDS 1965 score). Here again
should be stressed that NDDS 1965 takes into considera-
tion premorbid personality and personal history of affec-
tive illness, while the rest melancholic scales are largely
cross-sectional and do not include personality assess-
ment. Dark trough was of course lower than in controls,
but this finding suggests that the more melancholic fea-
tures the patient fulfilled, the closer its dark trough ampli-
tude was to normal.
It is believed that the biochemical alterations, which pro-
duce the EOG potentials take place in the pigmentum epi-
thelium. The origin of the light peak and dark trough
probably lies in the interaction between photoreceptors
and pigmentum epithelium [32], and dopamine seems to
hold a major role [24,25,32-35]. The role of melatonin
which is also reported to dysfunction in depression [12]
remains elusive [36].
Thus, the EOG findings of the current study could receive
two different interpretations: either dopamine activity is
decreased, or an advance of the circadian cycle might be
present, as already some authors have proposed [37,38].
Of course a combination of them could be present but
this is not in accord with the results of the current study,
since ERG findings were not significant. It is also possible
that one of them could be the result of the other. Another
important finding was the relationship of dark trough
with melancholia.
There are no reports in the international literature con-
cerning the different subtypes of depression. There are
only a few papers, and focus on seasonal depression.
Reports are inconclusive [39-45]. Light therapy acts on the
photoreceptors, at least in the initial phase [46]. Lam [47]
studied the EOG in 19 seasonal patients and reported the
presence of subtle disorders in the retina, at the photore-
ceptors level, resulting in a decreased light sensitivity, evi-
dent from lower Arden ratios in depressed patients in
comparison to controls. Terman et al [48] concluded that
it is possible that some environmentally induced, but
genetically determined state disorders of the photorecep-
tors contribute to the development of seasonal depres-
sion. They also suggested that these patients had light
hypersensitivity due to cone hypereactivity. Beersma [49],
suggested that this light hypersensitivity disturbs the
information arriving to the hypothalamus via the retino-
hypothalamic tract (single neurone) and subsequently the
functioning of the suprachiasmatic nucleus which seems
to posses properties of an endogenous pacemaker which
regulates the rhythms of the organism [50]. On the con-
trary, Reme [51] argues in favor of a reduced sensitivity to
light in seasonal patients. The disturbed functioning [52]
does not affect vision, but only those functions which
demand prolonged exposure to light (similar to light
therapy).
Leaving the area of seasonal depression, which is not the
direct focus of the current study, two are the only papers
investigating non-seasonal depression with EOG. Seggie
et al [40] reported that there were no differences in the
Arden ratios between 20 depressed patients and equal
number of controls, however depressed patients had
lower dark trough values. A careful study of the paper
reveals that there was no similar finding concerning the
light peak, probably due to small study sample, and if the
study sample was larger, such a finding could be possible.
The results of that study is to a large degree similar to ours.
Seggie et al concluded that depressed patients were light
supersensitive and located the disturbance at the receptor
level, and specifically in the rods. The authors of the cur-
rent study consider that these conclusions do not really fit
the data of that study. Economou and Stefanis [39] stud-
ied unipolar and bipolar patients and reported lower
Arden ratios in unipolar and higher in bipolars in compar-
ison to controls. They concluded that the existence and
the quality of psychomotor symptomatology and not the
mood of the patients is of prime importance, and related
their results to disorders of dopamine activity.
So, conclusively, in spite of the differences in interpreta-
tion, which is a difficult issue when only EOG is applied,
the results reported in the international literature are in
accord with the results of the current study.
b. flash-ERG
The a- wave is produced in the photoreceptors as they
respond to a light stimuli. The b-wave is neuronal in ori-
gin and largely reflects dopamine activity.
There are only scattered and unpublished reports (e.g.
Seggie et al: Electroretinographic Changes in Depression,
Proceedings of the 2nd Canadian Workshop on Epiphysis,
1990), and all suggest that there is an increased amplitude
and decreased latency of both the rods and the cones
response to the flash-ERG. These findings support theAnnals of General Psychiatry 2005, 4:7 http://www.annals-general-psychiatry.com/content/4/1/7
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existence of light hypersensitivity in depression. Similar
observations were made in animals during the transition
from light to dark conditions [53]. It has also been sug-
gested that the retinal disorders might relate to a toxic
effect of higher neurosteroid levels, which are produced
on the basis of excitatory impulses from NMDA receptors
through GABAA receptors. This arc is also influenced by
the light of the environment [54].
The results of the current study do not confirm the finding
of light hypersensitivity. Correlation results suggest that
melancholic features related positively with the photore-
ceptor sensitivity in darkness, and this relationship seems
to lie on a continuum.
c. Synthesis of findings
The major theories related to our findings are [55]:
a. The phase advance hypothesis (Wehr and Wirz-Justice),
which postulated that depressed patients get asleep too
late in comparison to the rest of their rhythms.
b. The S deficiency hypothesis (Borbely and Wirz-Justice),
which postulates that there is a disturbance in the home-
ostatic S procedure of sleep (reflecting the need of the
organisation for sleep)
c. The adrenergic-cholinergic imbalance hypothesis of
depression of Janowsky [56].
d. The proposal of von Zerssen et al [57] which suggests
that rhythms are independent from depression and just
intensify or attenuate the clinical picture in the same way
they affect normal mood.
e. The internal coincidence theory, which basically focuses
to the time of awakening. Wehr and Wirz-Justice again
suggested that there is a 'depressiogenic switch' which
normally is triggered and simultaneously inhibited by
other synchronous activities; however in depressive
patients the triggering occurs too early.
Wehr et al [58] tested the above theories by depriving 4
depressed patients (however only one unipolar) patients
from the environment, and thus isolating the endogenous
part of the rhythms. It is important to note that all patients
were impressively eager to accept this deprivation and all
were improved. They all expressed discomfort when the
experiment ended. This last observation is of prime
importance, since it can provide further data on the rela-
tionship between psychophysiological methods and
abnormal but different response to light stimuli under dif-
ferent conditions, and stressful life events.
Another key report is that sleep deprivation, according to
the review of Wu et al [59] immediately improves 67% of
melancholic and 48% of neurotic depressives. If we com-
bine this observation with the correlation of melancholia
with the dark trough, one could conclude that higher dark
trough values could predict better response to sleep depri-
vation. On the other hand, melancholics are considered
not to respond well to light therapy and atypical (neu-
rotic) patients share common clinical manifestations with
seasonal depression.
Since all depressed patients (according to the results of the
current study) had low dark trough and light peak values
in comparison to controls, but normal ERG, it is most
possible that the initial cause could lie in the pigmentum
epithelium, which secondary could affect the functioning
of the receptors. The change of rhythms could cause mild
affective symptomatology in normal subjects [60], but in
depression it is unlikely to be the prime disorder. Since
lesions in the pigmentum epithelium have not been yet
detected, this change in the functioning should be attrib-
uted to the change of the firing of the raphe nucleus,
which is considered to be an endogenous pacemaker.
There is no possibility of a spreading of the frontal lobe
metabolism dysfunction seen in depression, to the retina,
since, in the vast majority of cases, the ophthalmic artery
stems from the internal carotid artery.
However, since no differences were evident between mel-
ancholic and atypical patients, the source of the difference
in PR-VEPs latency between these two depressive subtypes
[14] should be traced posterior to the retina and anterior
to the chiasm. The problem is that the neurons that con-
stitute the optic nerve have their body located in the gan-
glionic layer of the optic nerve, which constitutes the
outer layer of the cerebral stratum, while their axons ter-
minate in the lateral geniculate body. It is obvious that the
part of the optic nerve from the retina to the chiasm con-
stitutes only a part of the optic nerve axon, and thus it is
very difficult to explain any dysfunction, which is so nar-
rowly localized. The only thing that differentiates this spe-
cific area is the fact that its blood supply come from small
vessels originating mainly from the anterior cerebral
artery [61, 62 and 63]
There is another possibility. EOG, ERG and PR-VEPs are
three different methods which can not be used simultane-
ously. Therefore, there might be some specific features
(e.g. eye micromovements) which have different influ-
ence on each of these tests or are activated or deactivated
during anyone of these tests, and thus contribute to the
results reported. In this case, our effort to localize the
dysfunction on the base of the results of our studies so far
is in vain.Annals of General Psychiatry 2005, 4:7 http://www.annals-general-psychiatry.com/content/4/1/7
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The advantages of the current study include the precise
diagnosis according to modern diagnostic criteria and the
detailed psychometric assessment. The major disadvan-
tage is the deviations from the International Society for
Clinical Electrophysiology of Vision (ISCEV) standards
for the recordings of EOG and ERG.
Conclusion
The main finding of the current study concerns the lower
dark trough and light peak values while ERG findings
were normal in all depressive subtypes. The above provide
the empirical foundation in order to incorporate the
reports of the international literature in a comprehensive
theory, which could explain the mechanism of action of
therapies like sleep deprivation and light therapy.
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